| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5695262 | Gynecologic Oncology | 2017 | 6 Pages |
Abstract
Preliminary data suggests that dose dense chemotherapy might be a reasonable and superior option for adjuvant treatment of endometrial cancer, compared to standard chemotherapy.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Liron Kogan, Ido Laskov, Zainab Amajoud, Jeremie Abitbol, Amber Yasmeen, David Octeau, Asma Fatnassi, Roy Kessous, Neta Eisenberg, Susie Lau, Walter H. Gotlieb, Shannon Salvador,